MGTX
MGTX
NASDAQ · Biotechnology

Meiragtx Holdings Plc

$9.49
-0.22 (-2.22%)
As of Oct 31, 10:27 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +564.0% upside
Low Target $47.40
Average Target $63.01
High Target $83.78
Current Price $9.49
Current
$9.49
Target
$63.01
$47.40 $63.01 avg $83.78
Scenario Analysis
Bear Case
$47.40
399.5%
Low target
Base Case
$63.01
+564.0%
Avg target
Bull Case
$83.78
+782.8%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$15.35
-38.2% from high
52-Week Low
$6.62
+43.4% from low
Target vs 52W High
$63.01
+310.5% vs high
Next Earnings Report
Nov 18, 2026
10d
until earnings
EPS Est: $-0.51
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%